Use of soluble CD164 variants in inflammatory and/or autoimmune disorders

Details for Australian Patent Application No. 2006207471 (hide)

Owner Laboratoires Serona S.A.

Inventors Proudfoot, Amanda; Saborio, Gabriela; Power, Christine

Agent Griffith Hack

Pub. Number AU-A-2006207471

PCT Pub. Number WO2006/077266

Priority 60/655,382 23.02.05 US; 05100432.3 24.01.05 EP

Filing date 24 January 2006

Wipo publication date 27 July 2006

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

26 July 2007 PCT application entered the National Phase

  PCT publication WO2006/077266 Priority application(s): WO2006/077266

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006207489-A process for the production of titanium dioxide using aqueous fluoride

2006207464-Method of preparing a nutritional composition